Up-regulation of GTSE1 lacks a relationship with clinical data in lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 2039-2043

  Tian, Tian ^a   Zhang, Zhipei ^b   Fei, Fei ^c   Li, Xiaofei ^b   Guo, Xu ^c   Liu, Boya ^b   Li, Jibin ^c   Chen, Zhinan ^a,c   Xing, Jinliang ^c  

^a BEIJING JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

GTSE1; Immunohistochemical staining; Lung cancer

Indexed keywords

EID: 84863289521     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Ambroise M, Ghosh M, Mallikarjuna VS, et al (2011). Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India. Asian Pac J Cancer Prev, 12, 625-9.
2. Bublik DR, Scolz M, Triolo G, et al (2010). Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment. J Biol Chem, 285, 5274-81.
3. Collavin L, Monte M, Verardo R, et al (2000). Cell-cycle regulation of the p53-inducible gene B99. FEBS Lett, 481, 57-62.
4. Fernandez S, Mosquera JL, Alana L, et al (2011). PTOV1 is overexpressed in human high-grade malignant tumors. Virchows Arch, 458, 323-30.
5. Hwang CF, Huang HY, Chen CH, et al (2011). Enhancer of Zeste homolog 2 overexpression in nasopharyngeal carcinoma: An independent poor prognosticator that enhances cell growth. Int J Radiat Oncol Biol Phys, (in press).
6. Kato T, Daigo Y, Aragaki M, et al (2011). Overexpression of MAD2 predicts clinical outcome in primary lung cancer patients. Lung Cancer, 74, 124-31.
7. Kim JG, Chae YS, Sohn SK, et al (2008). Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res, 14, 62-6.
8. Kong LM, Liao CG, Fei F, et al (2010). Transcription factor Sp1 regulates expression of cancer-associated molecule CD147 in human lung cancer. Cancer Sci, 101, 1463-70.
9. Lee HW, Choi YW, Han JH, et al (2009). Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. Lung Cancer, 65, 377-82.
10. Li A, King J, Moro A, et al (2011). Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer. Am J Pathol, 178, 1340-9.
11. Liu XS, Li H, Song B, et al (2010). Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery. EMBO Rep, 11, 626-32.
12. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C (T)) method. Methods, 25, 402-8.
13. Monte M, Benetti R, Buscemi G, et al (2003). The cell cycle-regulated protein human GTSE-1 controls DNA damage-induced apoptosis by affecting p53 function. J Biol Chem, 278, 30356-64.
14. Monte M, Benetti R, Collavin L, et al (2004). hGTSE-1 expression stimulates cytoplasmic localization of p53. J Biol Chem, 279, 11744-52.
15. Monte M, Collavin L, Lazarevic D, et al (2000). Cloning, chromosome mapping and functional characterization of a human homologue of murine gtse-1 (B99) gene. Gene, 254, 229-36.
16. Nagahara M, Nishida N, Iwatsuki M, et al (2011). Kinesin 18A expression: Clinical relevance to colorectal cancer progression. Int J Cancer, 129, 2543-52.
17. Schwartz GK, Shah MA (2005). Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol, 23, 9408-21.
18. Utrera R, Collavin L, Lazarevic D, et al (1998). A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. EMBO J, 17, 5015-25.
19. Wang S, Fang W (2011). Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma. Histopathology, 58, 217-24.
20. Yi C, Mu L, de lL, I, et al (2010). The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Res Treat, 120, 663-9.
21. Yoshitake K, Tanaka S, Mogushi K, et al (2011). Importin-alpha1 as a novel prognostic target for hepatocellular carcinoma. Ann Surg Oncol, 18, 2093-103.
22. Zhan N, Dong WG, Tang YF, et al (2011). Analysis of HER2 gene amplification and protein expression in esophageal squamous cell carcinoma. Med Oncol, (in press).